{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:55:35Z","timestamp":1772121335550,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.neurobiolaging.2005.04.004","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T07:20:07Z","timestamp":1117092007000},"page":"862-870","source":"Crossref","is-referenced-by-count":52,"title":["Neuroprotective effects of cystamine in aged parkinsonian mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Marie-\u00c8ve","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Saint-Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Rouillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0006-2952(91)90646-M","article-title":"Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"41","author":"Adams","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib2","first-page":"29","article-title":"Age-related susceptibility to MPTP-induced neurotoxicity in mice","volume":"14","author":"Ali","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1046\/j.1471-4159.2000.0751694.x","article-title":"Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain","volume":"75","author":"Beaudry","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00171038","article-title":"In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain","volume":"351","author":"Bel","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib6","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"PNAS"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib7","first-page":"S15","article-title":"Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson disease","volume":"44","author":"Chase","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib8","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism","volume":"60","author":"Chiueh","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib10","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410350107","article-title":"Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease","volume":"35","author":"Dexter","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Parkinson's: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0891-0618(00)00073-9","article-title":"Stereology, morphometry, and mapping: the whole is greater than the sum of its parts","volume":"20","author":"Glaser","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0092-8674(93)90718-6","article-title":"Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism","volume":"74","author":"Green","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0092-8674(94)90145-7","article-title":"Roads to neuralness: embryonic neural induction as derepression of a default state","volume":"77","author":"Green","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib16","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1096\/fasebj.5.15.1683845","article-title":"Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues","volume":"5","author":"Greenberg","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jnr.10702","article-title":"Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells","volume":"74","author":"Ientile","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0298-111","article-title":"Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch","volume":"18","author":"Igarashi","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib20","first-page":"197","article-title":"MPTP and aging. Studies in the C57BL\/6 mouse","volume":"60","author":"Irwin","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(92)90473-M","article-title":"The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL\/6 mice: a critical reassessment","volume":"572","author":"Irwin","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneur.62.3.351","article-title":"Progression of Parkinson disease: are we making progress in charting the course?","volume":"62","author":"Jankovic","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib23","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"PNAS"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib24","doi-asserted-by":"crossref","first-page":"PL27","DOI":"10.1016\/S0024-3205(97)01066-7","article-title":"S-Methylthio-cysteine and cystamine are potent stimulators of thiol production and glutathione synthesis","volume":"62","author":"Jokay","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib25","doi-asserted-by":"crossref","unstructured":"Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian M., Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. 2003;100:2047\u201352.","DOI":"10.1073\/pnas.0438021100"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","author":"Karpuj","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1471-4159.2003.01671.x","article-title":"Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner","volume":"85","author":"Kim","year":"2003","journal-title":"J Neuroschem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","article-title":"Glutathione peroxidase activity in Parkinson's disease brain","volume":"58","author":"Kish","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1460-9568.2003.02408.x","article-title":"The mouse MPTP model: gene expression changes in dopaminergic neurons","volume":"17","author":"K\u00fchn","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(01)00248-2","article-title":"Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain","volume":"106","author":"Langlois","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib32","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1046\/j.1471-4159.1999.02218.x","article-title":"Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury","volume":"73","author":"Le","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0304-3940(02)00981-3","article-title":"Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins","volume":"15","author":"Lee","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib34","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1074\/jbc.M205812200","article-title":"Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders","volume":"278","author":"Lesort","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib35","doi-asserted-by":"crossref","first-page":"14310","DOI":"10.1073\/pnas.93.25.14310","article-title":"Neurodegenerative diseases and transglutaminase","volume":"93","author":"Lorand","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00240602","article-title":"Transglutaminases","volume":"58","author":"Lorand","year":"1984","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(00)02926-7","article-title":"DNA damage in brain mitochondria caused by aging and MPTP treatment","volume":"885","author":"Mandavilli","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib38","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/00002826-199402000-00003","volume":"17","author":"Marsden","year":"1994","journal-title":"Clin Neuropharmacol Suppl"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib39","first-page":"978","article-title":"The role of glutathione in dopaminergic neuronal survival","volume":"52","author":"Nakamura","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib40","doi-asserted-by":"crossref","first-page":"34123","DOI":"10.1074\/jbc.274.48.34123","article-title":"Inhibition of \u201ctissue\u201d transglutaminase increases cell survival by preventing apoptosis","volume":"274","author":"Oliverio","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib41","series-title":"The rat brain in stereotaxic co-ordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.1989.tb02550.x","article-title":"Reduction of brain glutathione by l-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum","volume":"52","author":"Pileblad","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib43","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0006-291X(85)90230-X","article-title":"A catalyst function for MPTP in superoxide formation","volume":"131","author":"Poirier","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(95)00611-S","article-title":"Brain dopamine transporter: gender differences and effect of chronic haloperidol.","volume":"692","author":"Rivest","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib45","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1073\/pnas.95.7.4013","article-title":"Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons","volume":"95","author":"Saucedo-Cardenas","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","article-title":"Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration.","volume":"751","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib47","doi-asserted-by":"crossref","first-page":"34451","DOI":"10.1074\/jbc.M202099200","article-title":"The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes","volume":"277","author":"Serra","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib48","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1046\/j.1460-9568.2003.02885.x","article-title":"Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons","volume":"18","author":"Smits","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.2563176","article-title":"Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity","volume":"243","author":"Sonsalla","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.me.35.020184.003133","article-title":"Tardive dyskinesia","volume":"35","author":"Tarsy","year":"1984","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib51","doi-asserted-by":"crossref","unstructured":"Wang X, Sarkar A, Cicchetti F, Yu M, Zhu A, Jokivarsi K, Saint-Pierre M, Brownell A-L., Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6\/2 mouse model of Huntington's disease. J Neurol Sci 2005;231:57\u201366.","DOI":"10.1016\/j.jns.2004.12.011"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00001756-199603220-00018","article-title":"Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones","volume":"7","author":"Wullner","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.276.5310.248","article-title":"Dopamine neuron agenesis in Nurr1-deficient mice","volume":"276","author":"Zetterstrom","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2005.04.004_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jnen\/59.1.53","article-title":"Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase","volume":"59","author":"Zhang","year":"2000","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T22:46:15Z","timestamp":1706222775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458005001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0197458005001119"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.04.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1016223.323236","asserted-by":"object"}]},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}